Rabinowits, G., Homsi, J. ., Park, S., Khushalani, N. ., Panella, T. ., Ellison, D., Gentry, R., Venna, S., Strasswimmer, J., Zuniga, R. ., Chandra, S. ., Ruiz, E., Migden, M., Ibrahim, S., Mehta, N. ., Inocencio, T. ., He, X., Zhang, H., Gillis, K. ., & Pouliot, J.-F. (2023). CemiplimAb-rwlc Survivorship and Epidemiology (CASE): A prospective study of the safety and efficacy of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC) in a real-world setting. SKIN The Journal of Cutaneous Medicine, 7(2), s174. https://doi.org/10.25251/skin.7.supp.174